Literature DB >> 14634709

Response to: Parrott AC, Buchanan T, Heffernan TM, Scholey A, Ling J, Rodgers J (2003) Parkinson's disorder, psychomotor problems and dopaminergic neurotoxicity in recreational ecstasy/MDMA users. Psychopharmacology 167(4):449-450.

H R Sumnall1, L Jerome, R Doblin, M C Mithoefer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14634709     DOI： 10.1007/s00213-003-1599-3

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN： 0033-3158            Impact factor:   4.530


× No keyword cloud information.
  20 in total

1.  More about parkinsonism after taking ecstasy.

Authors:  M Baggott; J Mendelson; R Jones
Journal:  N Engl J Med       Date:  1999-10-28       Impact factor: 91.245

2.  Parkinsonism after taking ecstasy.

Authors:  S Mintzer; S Hickenbottom; S Gilman
Journal:  N Engl J Med       Date:  1999-05-06       Impact factor: 91.245

3.  Aminergic metabolites in cerebrospinal fluid of humans previously exposed to MDMA: preliminary observations.

Authors:  G A Ricaurte; K T Finnegan; I Irwin; J W Langston
Journal:  Ann N Y Acad Sci       Date:  1990       Impact factor: 5.691

4.  Prospective memory, everyday cognitive failure and central executive function in recreational users of Ecstasy.

Authors:  T. M. Heffernan; H. Jarvis; J. Rodgers; A. B. Scholey; J. Ling
Journal:  Hum Psychopharmacol       Date:  2001-12       Impact factor: 1.672

5.  Ecstasy/MDMA attributed problems reported by novice, moderate and heavy recreational users.

Authors:  A C Parrott; T Buchanan; A B Scholey; T Heffernan; J Ling; J Rodgers
Journal:  Hum Psychopharmacol       Date:  2002-08       Impact factor: 1.672

6.  Reduced in vivo binding to the serotonin transporter in the cerebral cortex of MDMA ('ecstasy') users.

Authors:  D M Semple; K P Ebmeier; M F Glabus; R E O'Carroll; E C Johnstone
Journal:  Br J Psychiatry       Date:  1999-07       Impact factor: 9.319

7.  Ecstasy use: cognitive deficits related to dosage rather than self-reported problematic use of the drug.

Authors:  H C Fox; A C Parrott; J J Turner
Journal:  J Psychopharmacol       Date:  2001-12       Impact factor: 4.153

8.  Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance.

Authors:  A C Parrott; J Lasky
Journal:  Psychopharmacology (Berl)       Date:  1998-10       Impact factor: 4.530

9.  Severe dopaminergic neurotoxicity in primates after a common recreational dose regimen of MDMA ("ecstasy").

Authors:  George A Ricaurte; Jie Yuan; George Hatzidimitriou; Branden J Cord; Una D McCann
Journal:  Science       Date:  2002-09-27       Impact factor: 47.728

10.  Serotonin neurotoxicity after (+/-)3,4-methylenedioxymethamphetamine (MDMA; "Ecstasy"): a controlled study in humans.

Authors:  U D McCann; A Ridenour; Y Shaham; G A Ricaurte
Journal:  Neuropsychopharmacology       Date:  1994-04       Impact factor: 7.853
View more
  2 in total

1.  Editorial note: MDMA-induced dopamine neurotoxicity.

Authors:  David M Warburton
Journal:  Psychopharmacology (Berl)       Date:  2003-11-21       Impact factor: 4.530

2.  The reality of psychomotor problems, and the possibility of Parkinson's disorder, in some recreational ecstasy/MDMA users: a rejoinder to Sumnall et al. (2003).

Authors:  A C Parrott; J Rodgers; T Buchanan; A B Scholey; T Heffernan; J Ling
Journal:  Psychopharmacology (Berl)       Date:  2003-11-21       Impact factor: 4.530
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.